Geographical inequalities in surgical treatment for localized female breast cancer, Queensland, Australia 1997-2011: Improvements over time but inequalities remain by Baade, Peter et al.
International  Journal  of
Environmental Research
and Public Health
Article
Geographical Inequalities in Surgical Treatment
for Localized Female Breast Cancer, Queensland,
Australia 1997–2011: Improvements over Time but
Inequalities Remain
Peter D. Baade 1,2,3,*, Paramita Dasgupta 1, Philippa H. Youl 1,3,4, Christopher Pyke 5
and Joanne F. Aitken 1,3,6,7
1 Cancer Council Queensland, P.O. Box 201, Spring Hill, QLD 4004, Australia;
paramitadasgupta@cancerqld.org.au (P.D.); pipyoul@cancerqld.org.au (P.H.Y.);
joanneaitken@cancerqld.org.au (J.F.A.)
2 School of Mathematical Sciences, Queensland University of Technology, Gardens Point,
Brisbane, QLD 4000, Australia
3 Menzies Health Institute Queensland, Griffith University, Gold Coast Campus, Parklands Drive,
Southport, QLD 4222, Australia
4 School of Public Health and Social Work, Queensland University of Technology, Herston Road,
Kelvin Grove, QLD 4059, Australia
5 Mater Medical Centre, 293 Vulture Street, South Brisbane, QLD 4101, Australia; c_pyke@mc.mater.org.au
6 School of Population Health, University of Queensland, Brisbane 4006, Australia
7 Institute for Resilient Regions, University of Southern Queensland, Toowoomba 4350, Australia
* Correspondence: peterbaade@cancerqld.org.au; Tel.: +61-7-3634-5317
Academic Editor: Paul B. Tchounwou
Received: 3 May 2016; Accepted: 15 July 2016; Published: 19 July 2016
Abstract: The uptake of breast conserving surgery (BCS) for early stage breast cancer varies by
where women live. We investigate whether these geographical patterns have changed over time
using population-based data linkage between cancer registry records and hospital inpatient episodes.
The study cohort consisted of 11,631 women aged 20 years and over diagnosed with a single primary
invasive localised breast cancer between 1997 and 2011 in Queensland, Australia who underwent
either BCS (n = 9223, 79%) or mastectomy (n = 2408, 21%). After adjustment for socio-demographic
and clinical factors, compared to women living in very high accessibility areas, women in high (Odds
Ratio (OR) 0.58 (95% confidence intervals (CI) 0.49, 0.69)), low (OR 0.47 (0.41, 0.54)) and very low
(OR 0.44 (0.34, 0.56)) accessibility areas had lower odds of having BCS, while the odds for women from
middle (OR 0.81 (0.69, 0.94)) and most disadvantaged (OR 0.87 (0.71, 0.98)) areas was significantly
lower than women living in affluent areas. The association between accessibility and the type of
surgery reduced over time (interaction p = 0.028) but not for area disadvantage (interaction p = 0.209).
In making informed decisions about surgical treatment, it is crucial that any geographical-related
barriers to implementing their preferred treatment are minimised.
Keywords: breast cancer; geography; inequalities; mastectomy; breast conserving surgery; socioeconomic
1. Introduction
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer mortality
among females worldwide, accounting for 25% of total cancer cases and 15% of all cancer deaths in
2012 [1]. Current evidence-based recommendations for the management of early breast cancer state
that when breast conserving surgery (BCS) is not clinically contraindicated, all women should be given
an informed choice between BCS and mastectomy [2–4]. Although both procedures are considered
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clinically equivalent in terms of survival [5], BCS is less invasive and is associated with improved
quality of life outcomes pertaining to body image, sexuality, self-esteem, and social adjustment [6–11].
Moreover, women receiving BCS were shown to have fewer post-operative complications than
mastectomy [12,13]. Given ongoing improvements in survival, cosmetic and psychosocial outcomes
following breast cancer treatment, may become increasingly important as a decisive factor during
treatment decision-making.
Despite these guidelines, widespread geographical and socioeconomic variations in the clinical
management and patterns of care for early stage breast cancer persist, in particular, rural and more
disadvantaged women are consistently less likely to receive BCS [14–24] than their urban or less
disadvantaged counterparts. These disparities are widely attributed to a combination of clinical,
demographic, environmental, and healthcare system factors including geographical access to and
availability of specialised care, comorbidities, and patient preferences [14–16,18,19,21–23,25–30].
Among Australian women, geographical variations in breast cancer patterns of care are well
documented with studies based on the Breast Cancer Audit which includes about 60% of all early breast
cancer cases diagnosed in Australia reporting that rural [16,22,23] and disadvantaged women [15]
were more likely to undergo a mastectomy independent of the tumour size. Similar patterns were also
found by several cancer-registry linkage studies [20,21,24].
Previously, we reported on the patterns of surgical treatment for women diagnosed with early
breast cancer during 2004 in Queensland, Australia [24]. Here we update and extend that work to
explore whether there is any evidence of changes in the likelihood of women being treated with BCS
rather than mastectomy over the fifteen-year period between 1997 and 2011.
Various initiatives have been developed over the last decade to improve access to quality cancer
care for patients in rural, remote and other disadvantaged settings in Australia such as establishment
of regional cancer care centres [31,32] and innovative models of care [33,34]. However, to the best of
our knowledge, the impact of such initiatives on geographical patterns of care for breast cancer, have
not been previously explored at a population level.
2. Materials and Methods
Ethical approval to conduct this study was obtained from the Griffith University Human Research
Ethics Committee (GU Ref No: PBH/34/13/HREC). Queensland Health gave legislative consent to
access the routinely collected population-based dataset of incident breast-cancer cases, and to link it
with the Queensland Hospital Admitted Patient Data Collection (QHAPDC) [35].
Data was obtained from the Queensland Cancer Registry (QCR) for all women aged at least
20 years diagnosed with a first and only primary histologically verified invasive breast cancer (ICD-O3
C50) between 1997 and 2011 [36] with known geographical information, tumour size, and lymph node
involvement. By definition our exclusion criteria excluded any women with synchronous bilateral
breast cancer at the time of initial presentation. Likewise, metachronous and recurrent breast cancers
were also excluded. Only women with a first primary invasive breast cancer were considered as a
prior cancer diagnosis may have impacted breast cancer treatment. Women with unknown tumour
size or nodal information (2941, 8%) were also excluded. Information on hormone receptor status is
not collected by the QCR. Variables extracted included age, year, partner status, Indigenous status
(self-identified), breast cancer morphology, histology, tumour size, lymph node status, as well as
information regarding any subsequent invasive primary (non-breast) cancers diagnosed according
to the international rules for coding multiple primaries [37]. Women with no additional invasive
(non-breast) cancers following their initial breast cancer were classified as “solitary” breast cancer cases.
In the absence of stage information, data collected since 1997 on tumour size and lymph node
status [36] enabled a proxy measure of breast cancer stage at diagnosis to be calculated [38]. This study
was restricted to women diagnosed with localised disease which was defined as tumours with a
diameter of 20 mm or less with no evident nodal spread or metastases.
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2.1. Treatment and Comorbidities
A deterministic link based on hospital and admitted patient number between the QCR and the
QHDAPC database was used to obtain information on all breast-cancer related surgical procedures
and comorbidities [24,39]. All women in the cohort were followed for up to two years after their breast
cancer diagnosis consistent with previous studies [24,40], with the latest follow-up being 31 December
2013. Multiple records were possible for the same woman. Our comorbidity information was limited
to those recorded in hospital charts during an inpatient episode of care within the two-year period
following the breast cancer.
2.1.1. Surgical Procedures
The cohort was restricted to women who had either a BCS or mastectomy during the study
period. A woman was assumed to have undergone a specific procedure if it was identified on at least
one linked hospital record. Prior to 1 July 1998 all surgical procedures were coded using ICD-9-CM
codes; but from that date forward they were coded in ICD-10-AM [41,42]. Surgical procedures were
categorised as BCS (ICD-9-CM code 85.20–85.23, ICD-10-AM block codes 1744–1745) or mastectomy
(ICD-9-CM code 85.41–85.48, ICD-10-AM block codes 1747–1749) (see Table S1).
2.1.2. Hospital Type
Each woman was allocated a hospital volume, based on the annual breast-cancer related surgical
caseload of the hospital where they underwent surgery and also categorised as either public or
private [35].
2.1.3. Comorbidities
Hospital comorbidities are conditions that either co-existed with or arose during at least one
breast-cancer related inpatient stay and which influenced a patient’s clinical management. Data on
all comorbidities included in the Charlson Comorbidity Index were obtained based on diagnostic
codes (see Table S1) [42]. The Charlson Comorbidity Index (CCI) score [42,43] was then collapsed
to none (CCI = 0), low (CCI = 1), or moderate/severe (CCI ě 2). We excluded cancers from this list
as we were unable to ascertain whether the recorded cancer was independent of the primary breast
cancer diagnosis.
2.2. Geographical
Each woman was assigned a Statistical Local Area (SLA) according to the Australian Standard
Geographical Classification [44] based on the geocoded coordinates of her residence at diagnosis.
SLAs are administrative units that cover the whole of Queensland with no gaps or overlaps that are
deemed to be socio-economically relevant to their residents and relatively homogeneous in terms of
the population covered [38,44]. In 2011, the median population among 478 SLAs in Queensland was
6390 (range 2: 83,600). Women were then categorized into four accessibility groups (see Table 1) based
on the road travel time from their residential SLA to the closest radiation facility [45]. Radiation facilities
in Queensland are typically affiliated to major cancer care centres, hence these distances serve as a proxy
measure of access to optimum oncological services and so better reflect access from the perspective of
specialist cancer treatment facilities than more generic area-based classifications such as the Australian
Accessibility/Remoteness Index [46].
Area-level socioeconomic status was measured according to the SLA-based Index of Relative
Socioeconomic Advantage and Disadvantage (IRSAD) which was developed by the Australian Bureau
of Statistics and ranks SLAs in Australia according to their relative socio-economic advantage and
disadvantage [47]. The IRSAD summarises information about the socio-economic status of people and
households within an SLA, comprising both relative advantage and disadvantage measures.
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Women who were not matched to any hospital treatment records were excluded to avoid potential
misclassification as we could not be certain if they had undergone treatment interstate, had no
treatment, or if the missing information was due to errors in the data linkage processes [24,39].
Women with missing geographical information (less than 0.05% of cohort) were also excluded.
Table 1. Cohort of women with a first primary localised breast cancer, Queensland 1997–2011 having
breast conserving surgery.
Variable Numbers Breast Conserving Surgery (BCS)
N (col %) N (%) HavingBCS
Adjusted Odds Ratio (BCS: Mastectomy
with 95% Confidence Interval in Brackets) 2
Number of women in cohort 11,631 (100.0) 9223 (79.3)
Residential disadvantage p < 0.001 1 p = 0.013 3
Least disadvantaged 2044 (17.6) 1797 (87.9) 1.00
Middle socioeconomic status 8237 (70.8) 6440 (78.2) 0.81 (0.69, 0.94)
Most disadvantaged 1350 (11.6) 986 (73.0) 0.87 (0.71, 0.98)
Accessibility p < 0.001 p < 0.001
Very high (<1 h) 8523 (73.3) 7157 (84.0) 1.00
High (1–2 h) 932 (8.0) 653 (70.1) 0.58 (0.49, 0.69)
Low (2–6 h) 1817 (15.6) 1179 (64.9) 0.47 (0.41, 0.54)
Very low (ě6 h) 359 (3.1) 234 (65.2) 0.44 (0.34, 0.56)
Age at diagnosis (years) p < 0.001 p < 0.001
<40 586 (5.0) 466 (79.5) 0.80 (0.63, 1.01)
40–49 1969 (16.9) 1613 (81.9) 0.86 (0.74, 1.01)
50–59 3277 (28.2) 2755 (84.1) 1.00
60–69 3336 (28.7) 2656 (79.6) 0.77 (0.68, 0.88)
70–79 1871 (16.1) 1349 (72.1) 0.53 (0.45, 0.61)
ě80 592 (5.1) 384 (64.9) 0.40 (0.32, 0.49)
Year of diagnosis 4,5 p < 0.001 p = 0.002
1997 507 (4.4) 353 (69.6) 1.00
1998 594 (5.1) 443 (74.6) 1.03 (0.99, 1.07)
1999 632 (5.4) 486 (76.9) 1.17 (1.13, 1.21)
2000 678 (5.8) 549 (81.0) 1.27 (1.22, 1.32)
2001 668 (5.7) 540 (80.8) 1.48 (1.43, 1.54)
2002 705 (6.1) 576 (81.7) 1.49 (1.43, 1.54)
2003 704 (6.1) 565 (80.3) 1.55 (1.49, 1.61)
2004 744 (6.4) 594 (79.8) 1.57 (1.51, 1.62)
2005 788 (6.8) 646 (82.0) 1.63 (1.57, 1.69)
2006 838 (7.2) 687 (82.0) 1.51 (1.46, 1.56)
2007 792 (6.8) 634 (80.1) 1.53 (1.48, 1.59)
2008 927 (8.0) 736 (79.4) 1.49 (1.44, 1.54)
2009 1009 (8.7) 789 (78.2) 1.48 (1.43, 1.52)
2010 1040 (8.9) 825 (79.3) 1.32 (1.28, 1.36)
2011 1005 (8.6) 800 (79.6) 1.30 (1.26, 1.34)
Partner 6 p < 0.001 p = 0.036
Partnered 7427 (63.9) 6003 (80.8) 1.00
No partner 3937 (33.8) 2990 (75.9) 0.94 (0.84, 0.96)
Unknown 267 (2.3) 230 (86.1) 1.40 (0.95, 2.06)
Indigenous p < 0.001 p = 0.045
Non-Indigenous 10,177 (87.5) 7993 (78.5) 1.00
Indigenous 87 (0.7) 62 (71.3) 0.96 (0.71, 1.78)
Unknown 1367 (11.8) 1168 (85.4) 1.23 (1.02, 1.47)
Histology p < 0.001 p < 0.001
Ductal (8500-3) 8994 (77.3) 7168 (79.7) 1.00
Lobular (8520-3) 1094 (9.4) 808 (73.9) 0.73 (0.62, 0.85)
Other 1543 (13.3) 1247 (80.8) 1.11 (0.96, 1.28)
Size (mm) p < 0.001 p < 0.001
<10 mm 3905 (33.6) 3260 (83.5) 1.00
10–20 mm 7726 (66.4) 5963 (77.2) 0.75 (0.67, 0.83)
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Table 1. Cont.
Variable Numbers Breast Conserving Surgery (BCS)
N (col %) N (%) HavingBCS
Adjusted Odds Ratio (BCS: Mastectomy
with 95% Confidence Interval in Brackets) 2
Grade p < 0.001 p <0.001
Low 3391 (29.2) 2829 (83.4) 1.00
Intermediate 4754 (40.9) 3727 (78.4) 0.76 (0.67, 0.86)
High 2370 (20.4) 1839 (77.6) 0.67 (0.58, 0.77)
Unknown 1116 (9.5) 828 (74.2) 0.63 (0.52, 0.76)
Multiple primary cancers 7 p < 0.001 p <0.001
No 10,941 (94.1) 8760 (80.1) 1.00
Yes 690 (5.9) 463 (67.1) 0.53 (0.44, 0.64)
Comorbidity 8 p < 0.001 p = 0.022
None 11,027 (94.8) 8807 (79.9) 1.00
Low 491 (4.2) 347 (70.7) 0.76 (0.61, 0.95)
Moderate/severe 113 (1.0) 69 (61.1) 0.62 (0.41, 0.94)
Hospital type p < 0.001 p <0.001
Public 5106 (43.9) 3834 (75.1) 1.00
Private 6525 (56.1) 5389 (82.6) 1.48 (1.33, 1.64)
Hospital volume 9 p < 0.001 p <0.001
0–74 3761 (32.3) 2763 (73.5) 1.00
75–99 1636 (14.1) 1121 (68.5) 0.78 (0.68, 1.02)
ě100 6234 (53.6) 5339 (85.6) 1.58 (1.41, 1.78)
1 p values from Pearson’s chi square test; 2 Models adjusted for all covariates; 3 p-values from Wald’s joint
test of coefficients for multivariate logistic regression; 4 Year was modelled as a continuous variable with
restricted cubic splines. 5 The parameter estimates for cubic splines for year of diagnosis have no interpretation
in themselves, hence predicted odds ratios and their 95% CI were calculated using the predicted probabilities
from the model 6 Partner includes married and partnered; no partner includes never married/single, widowed,
separated and divorced; 7 Other invasive cancers following breast cancer; 8 Based on Charlson Comorbidity
Index (CCI) score: none (CCI = 0), low (CCI = 1) and moderate/severe (CCI ě 2); 9 Annual breast cancer
surgical caseload.
2.3. Analyses
Bivariate associations were explored using chi-squared tests. Multivariate logistic regression
models were then used to identify key predictors of BCS as opposed to mastectomy, including checking
that model assumptions such as lack of collinearity were met with appropriate diagnostic tests in
Stata (StataCorp, College Station, TX, USA). No evidence for collinearity between variables was found
when assessing the variance inflation factor. A stepwise model building process was used, in which all
variables (Table 1) were initially entered into the model before sequentially removing those deemed
non-significant (p > 0.20) to obtain the provisional reduced final model. Each of the dropped variables
was then tested individually to determine whether their inclusion improved the model fit using the
likelihood ratio test. Goodness of fit was also assessed graphically based on model residuals.
We examined whether the patterns for BCS by accessibility or residential disadvantage varied
over time by separately including interaction terms between these explanatory variables and the year
of diagnosis in the corresponding main effect model. Interaction terms were considered statistically
significant if p ď 0. 05 (Wald χ2 test) for the overall effect.
Initial tests of bivariate associations (not shown) highlighted that the individual effects of the
ordinal variables of age and year of diagnosis on the probability of having BCS were not linear.
We explored various transformations, including restricted cubic splines. For age, we found there was
little difference in model fit between categorizing age (categories in Table 1) and the cubic splines,
so for ease of presentation age was included as a categorical variable. For year of diagnosis, the cubic
splines provided the best fit with two degrees of freedom for the knots and have been used in the
adjusted models.
All statistical analyses were performed with Stata/SE version 14 (StataCorp, College Station,
TX, USA). Parameter estimates from main-effect models are presented as adjusted odds ratios (OR)
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with their 95% confidence intervals (CI). Since the parameter estimates for cubic splines for year of
diagnosis have no interpretation in themselves, we calculated the predicted odds ratios, and their 95%
CI, using the predicted probabilities from the model [48]. Likelihood ratio tests were used to assess the
contribution of each variable to model fit, with statistical significance taken to be p ď 0.05.
The average adjusted predicted probabilities of having BCS for a specified combination of
covariates were estimated from the fully adjusted interaction models and expressed as a percentage.
Sensitivity analyses using varying cut-points ranging from 50 to 200 cases per year to define high
caseload hospitals and comparison of observed and predicted probabilities of undergoing BCS were
used to guide our choice of most appropriate way of modelling this variable, with the final cut-points
being 0–74, 74–99 and ě100 cases per year.
Additional sensitivity analyses assessing the impact of unknown stage on observed associations
were carried out by repeating the analyses assuming that all cases with unknown stage were localised
or by randomly assigning them equally to localised and advanced categories.
3. Results
3.1. Cohort Characteristics
Of the 35,693 cases of invasive female breast cancer in Queensland between 1997 and 2011,
16,445 (46%) women who were diagnosed with localized disease aged 20 years and over and had
known geographical information, initially comprised the study cohort. The exclusion of cases without
a matching hospital record (n = 1399, 4%), a prior invasive cancer diagnosis (n = 918, 3%), who had
both mastectomy and BCS (n = 1318, 4%) or a linked axillary staging procedure (n = 212, <1%) and
those with multiple breast cancers (n = 967, 3%) gave a final cohort of 11,631 women. Of these,
3% lived in areas categorized as having very low accessibility and 12% in areas classified as being most
disadvantaged (Table 1). The median age at breast cancer diagnosis was 59 years (interquartile range:
51–68 years).
Over half (56%) of the women had surgery at a private hospital, and 54% at a hospital with
an annual caseload of at least 100 (high volume). However, these proportions varied by residential
location, with women living in high and very highly accessibility areas or from more advantaged areas
being significantly more likely (p < 0.001) to attend a high volume or private hospital.
3.2. Associations with Likelihood of Having BCS
Overall, 9223 women (79%) in the cohort underwent BCS and 2403 (21%) a mastectomy during
the two-year of follow-up since diagnosis (Table 1). Over the study period (1997–2011), there was a
statistically significant increase in the percentage of women undergoing BCS (p < 0.001) from around
70% in 1997 to 81% in 2000, after which it became relatively stable for the remainder of the study
period (fluctuating between 78% and 82%).
All of the covariates considered in this study (Table 1) had a significant (log rank test: p < 0.001)
bivariate association with BCS. After adjustment in the multivariable model, for some variables the
strength of the association reduced, however all were significant at the 5% level.
After adjustment for socio-demographic and clinical factors, women who lived in high
(OR 0.58 (95% CI 0.49, 0.69)), low (OR 0.47 (0.41, 0.54)) and very low (OR 0.44 (0.34, 0.56)) accessibility
areas had significantly lower odds of having BCS than their counterparts from very high accessibility
areas. Women from middle (OR 0.81 (0.69, 0.94)) or most disadvantaged (OR 0.87 (0.71, 0.98)) areas
also had lower odds of BCS than residents of least disadvantaged areas. Other independent predictors
of lower uptake of BCS included higher grade, comorbidities or a subsequent diagnosis of another
primary invasive (non-breast) cancer. By contrast the odds of women having BCS at a high caseload
(ě100 versus <75, OR 1.58 (95% CI 1.41, 1.78)) or a private (versus public, OR 1.48 (1.33–1.64)) hospital
were significantly higher (Table 1).
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3.3. Interaction Models
The interaction between the effects of accessibility and year of diagnosis on the likelihood of
having BCS was statistically significant (p = 0.028). Although the estimated percentage of women from
very high accessibility areas having BCS was consistently higher than the corresponding percentages
for high, low and very low accessibility areas for each year of diagnosis, the magnitude of these
differences narrowed over time (Figure 1). For example, these percentages increased slightly over time
from 47% (1997) to 61% (2011) for women living in very low accessibility areas whereas they remained
around 81% for women from very high accessibility areas. The non-overlapping confidence intervals
for the very low or low accessibility areas and those of the very high accessibility areas highlighted that
the significant geographical difference in the likelihood of BCS remained over the whole study period.
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Figure 1. Estimated number of women with localised breast cancer out of 100 (percentage) undergoing
breast conserving surgery (BCS) by accessibility and year of diagnosis, Queensland 1997–2011.
While there was a suggestion of converging patterns in the percentages of women receiving
BCS by area disadvantage during the late 1990s (Figure 2), these curves had plateaued since 2000,
meaning that overall there was no statistical evidence that the association between area disadvantage
and likelihood of BCS (interaction p = 0.209) had changed over time.
4. Discussion
This study was designed to examine temporal changes in geographical patterns of BCS by
residential location as measured by accessibility and area-disadvantage. Among women diagnosed
with localised breast cancer in Queensland, Australia, we found that the likelihood of receiving BCS
as opposed to mastectomy varied by geographical location. In particular, after adjusting for other
variables, women living in low and very low accessibility areas were significantly less likely to undergo
BCS than those living in very high accessibility areas. Women from disadvantaged areas were also less
likely to undergo BCS than their counterparts living in more affluent areas. Our results were consistent
with other Australian studies that reported lower uptake of BCS among women living in more remote
or disadvantaged areas [15,16,20–24].
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Figure 2. Estimated number of women with localised breast cancer out of 100 (percentage) undergoing
BCS by residential disadvantage and year of diagnosis, Queensland 1997–2011.
However, to the best of our knowledge ours is the first study to investigate whether these
geographical patterns have changed over time. Given ongoing improvement in the provision of cancer
care in regional Australia over the past decade, this type of study can serve to examine the potential
impact of the addition of these services on patterns of cancer care and may provide a be chmark for
future studies in this area. While we found statistical evidence of a change in these patterns for women
diagnosed over a period of 15 years, in practice the changes were slight and in the most recent year
of diagnosis women from areas of lower accessibility or more disadvantage were still less likely to
n ergo S than those living in highest accessibility or least disadvantaged areas. It remains to be
seen whether they are suggestive of a definite change in geographical inequalities.
Australian clinical practice guidelines for early breast cancer management stipulate that where
clinically appropriate, women should be offered the choice of either BCS with adjuvant radiotherapy,
or mastectomy [4], as curative surgical treatment, as both are considered clinically equivalent in terms
of survival [5]. However, women should also be informed that body image is better preserved with
BCS during the treatment decision-making process [4]. Given the well-documented inequitable cancer
care across population-subgroups by geographical location in Australia [15,16,22–24], our evidence for
a reduction in geographical disparities in patterns of surgical treatment (after adjustment) is supportive
of some reduction in the impact of distance-related geographical barriers to accessing cancer care.
Importantly, since distance is not only a barrier to access in itself but contributes to disproportionate
financial costs [49], and psychosocial outcomes [50] of breast cancer patients needing to travel for
treat ent, this evidence is encouraging.
In most cases, adjuvant radiotherapy is recommended with BCS to reduce the risk of long-term
recurrence for women diagnosed with breast cancer [3,4]. Thus our finding that women who lived
in less accessible areas were less likely to have BCS is not surprising, and is consistent with other
studies showing that women living in rural areas or further away from radiotherapy facilities are
less likely to undergo BCS and adjuvant radiotherapy following BCS across Australia [15,21,22,51]
and the United States [18,19,26,52]. The following scenarios would indicate an inequity in access to
care; first, when women from areas of less accessibility were not offered the opportunity to make an
informed decision regarding BCS versus mastectomy where it was clinically appropriate, or second,
when women had a mastectomy solely due to difficulties in accessing radiotherapy services even if they
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preferred BCS. A recent Australian study highlighted how access to treatment impacts on treatment
choice, with a greater proportion of women diagnosed with breast cancer having BCS following
the opening of a local publicly funded radiotherapy centre in their local area [53]. While there has
been an expansion of radiotherapy infrastructure in regional centres since 2011 [32], the last year
of our study cohort, our categories of accessibility have taken that into account, so this expansion
cannot explain the reducing impact of distance on the choice of surgical treatment. Previously, it
was suggested that a surgeon’s preference had been a factor in this disparity [54,55], however the
current study shows that most patients were treated in high volume centres, making this less likely.
Specialisation, as measured by annual breast cancer surgical caseload can influence surgical treatment
with lower-caseload surgeons being more likely to prefer a mastectomy [54–56]. Treatment at high
volume hospitals with site-specific multidisciplinary teams and specialised surgeons with expertise in
performing BCS is however an independent predictor of BCS with adjuvant radiotherapy [23,24,55–57].
Other confounding influences on BCS rates such as the rise of “oncoplastic surgery” [58], and the
acceptance of narrower margins of excision in attempting BCS [59] are more relevant to the time period
immediately after the 2011 cohort.
Other contributing factors to the narrowing geographical disparities over time may include
improved access to specialist services and breast cancer surgeons through establishment of regional
cancer centres [31,32], the adoption of novel approaches to improve both the efficiency and quality
of cancer services for people in less accessible settings (such as telehealth and integrated service
networks) [33,34] as well as changes in perceptions of BCS versus mastectomy. We lack the information
in our study cohort to explore these issues further. Studies from Australia [15,16,20,21,24,25],
Europe [14,27], Canada [17], and the United States [18,19,26] have however consistently reported
associations between sociodemographic, clinical, geographical and health-care factors and patterns of
surgical care for early breast cancer suggesting that there are other factors, apart from accessibility and
area disadvantage, that drive the choice of BCS versus mastectomy.
We found no evidence for a significant reduction in the disparities of BCS by residential
disadvantage over time. Our measure of residential disadvantage includes both relative advantage and
disadvantage measures such as low and high educational attainment, unemployment, occupation type,
as well as low and high income [47] and is based on SLAs that are deemed relatively homogenous in
terms of the covered populations [44]. The underlying reasons for the persistent variations in surgical
patterns by residential disadvantage are unclear. The QCR [36] does not collect information on potential
confounders such as measures of individual socioeconomic status including income, education, and
health insurance status [15,19,52,60,61]. Unmeasured variations in general health status at time of
breast cancer diagnosis is another possibility as more disadvantaged women are known to have poorer
health and a higher prevalence of comorbidities [62] which may influence treatment decisions [30].
More disadvantaged women may also experience greater financial and structural barriers to accessing
specialised care and/or high-volume hospitals [63–65] both of which are independent predictors of
care in accordance to guidelines (and higher receipt of BCS) [23,24,55–57].
Treatment-decision making is a complex procedure which is impacted by choices offered to
a patient by their clinician and patient preferences. Clinicians typically consider factors such as
comorbidities, age, clinical characteristics, and ability to tolerate adjuvant therapy when recommending
treatment [2]. Two recent reviews [28,66] suggested that a mix of issues, including those related to body
image, fertility, concerns about survival or recurrence, quality of life, and clinician preferences were key
drivers for a woman’s preference of surgical treatment and adjuvant therapies for early breast cancer.
In one review, Hamelinck and colleagues [28] found that, for some women, survival was a decisive
factor in their preference for mastectomy over BCS, which is of concern given that both approaches
have clinically equivalent survival [5], suggesting existing limitations in the effective communication
of medical information that adequately explains the risks and benefits of both approaches.
To the best of our knowledge, no Australian study has explored how the provision of medical
information by clinicians to women diagnosed with breast cancer varied by geographical location,
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and whether there is any differential impact of this information on patient choice. It remains a priority
to ascertain how the provision of information to patients impacts on the decision making process,
and how this can be improved by health care providers and other support personnel. However, it
is one thing to ensure that all women are provided information about the possible surgical options
following a diagnosis of breast cancer, it is another thing to ensure that all the options discussed are
available to women regardless of where they live. With the decentralised population in Queensland,
and large geographical distances, efforts to ensure equitable access to services in all areas will continue
to be an issue.
Strengths and Limitations
The strengths of this study include the use of 15 years of diagnostic data from a robust state-wide
population-based cancer registry to which notification of all invasive breast cancers diagnosed in
Queensland is a statutory requirement [36]. Our population-based data linkage approach, using a
deterministic linkage method, also allowed us to identify breast-cancer related surgical procedures
within two years of diagnosis at all public and private hospitals within Queensland and selected
hospital non-cancer comorbidities.
However, important limitations remain including our inability to adjust for more detailed patient
socio-demographics, lifestyle and psychosocial variables, and important clinical factors such as
hormone receptor status [22,23,25], family history [51], and adjuvant therapies [21,22,25] that may
have influenced treatment decisions but are not collected by the accessed administrative databases.
Information on surgical status and selected comorbidities were obtained through a deterministic
linkage between the QCR and QHAPDC. As such, this data would be missing for women who received
subsequent treatment interstate or overseas [39]. We acknowledge that some instances of surgery may
also have been missed due to errors in the notification or data linkage process [24,40].
Our comorbidity information was limited to those within two years of diagnosis that were
considered by hospital staff to have directly impacted on treatment, and so may have been
underestimated. We were unable to assess the influence of pre-existing comorbidities on breast-cancer
related treatment decisions, however international studies report that pre-existing conditions have
tended to be associated with an increased likelihood of receiving mastectomy [30].
Around 8% of cases could not be staged and were excluded from the analyses.
However, sensitivity analyses showed that the association between decreasing accessibility, increasing
disadvantage, and lower rates of BCS remained, regardless of the assumptions made about the true
distribution of unknown stage cancers. Given their very small numbers, the exclusion of women
lacking geographical information is unlikely to have any impact on results.
5. Conclusions
Our results suggest that distance as a barrier to accessing treatment may have reduced over time.
Since we are limited in our ability to examine in depth the underlying reasons for these changes, both
the drivers of the geographical variations in surgical patterns by area disadvantage and the temporal
trends in these patterns remain unclear, although environmental, structural, social, and economic
factors remain plausible explanations. As such although the temporal reduction in the geographical
variation in the type of surgical care for women diagnosed with localised breast cancer is encouraging,
further research to identify the drivers of existing disparities, especially those related to health care
system, area disadvantage, provision of adequate information and decision making factors remains a
priority. It is crucial that all women diagnosed with breast cancer not only have the opportunity to
make informed decisions about their care and treatment in partnership with clinicians, but that any
geographical-related barriers to implementing their preferred treatment are minimised.
Supplementary Materials: The following are available online at www.mdpi.com/1660-4601/13/7/729/s1,
Table S1: ICD-9-CM and ICD-10-AM procedure and disease codes.
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